1. Home
  2. IMRN vs OBAI Comparison

IMRN vs OBAI Comparison

Compare IMRN & OBAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immuron Limited

IMRN

Immuron Limited

N/A

Current Price

$1.07

Market Cap

9.4M

Sector

Health Care

ML Signal

N/A

Logo TG-17 Inc. Common Stock

OBAI

TG-17 Inc. Common Stock

N/A

Current Price

$0.19

Market Cap

9.4M

ML Signal

N/A

Company Overview

Basic Information
Metric
IMRN
OBAI
Founded
1994
2017
Country
Australia
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Telecommunications Equipment
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
9.4M
9.4M
IPO Year
2016
2025

Fundamental Metrics

Financial Performance
Metric
IMRN
OBAI
Price
$1.07
$0.19
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
122.7K
★ 562.5K
Earning Date
08-28-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 40.53
EPS
★ N/A
N/A
Revenue
N/A
★ $9,972,000.00
Revenue This Year
$16.39
N/A
Revenue Next Year
N/A
$76.34
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 2.42
52 Week Low
$0.68
$0.18
52 Week High
$2.38
$19.95

Technical Indicators

Market Signals
Indicator
IMRN
OBAI
Relative Strength Index (RSI) 41.29 17.54
Support Level $1.06 N/A
Resistance Level $1.22 $13.10
Average True Range (ATR) 0.07 0.26
MACD -0.01 -0.31
Stochastic Oscillator 12.77 0.04

Price Performance

Historical Comparison
IMRN
OBAI

About IMRN Immuron Limited

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company with a proprietary technology platform focused on polyclonal antibodies that can address unmet medical needs. The company's commercial products are: Travelan (an orally administered passive product indicated to reduce the risk of travelers' diarrhea and minor gastrointestinal disorders), and Protectyn, which is marketed as an immune supplement. Additionally, it has two clinical products in development, IMM124-E and IMM529, for the treatment of multiple high-value enteric disease indications. The firm has two reportable segments: Hyper-immune products, which derive maximum revenue, and Research and development. Geographically, the company generates maximum revenue from Australia, followed by the USA and Canada.

About OBAI TG-17 Inc. Common Stock

Our Bond Inc is a personal security service through its AI-powered Preventive Personal Security platform. It is trusted by corporations, cities, and universities, and has already supported many security service requests, emergencies and life-saving interventions. The cloud-based Bond Preventative Personal Security Platform provides users with remote protective services via phone app (using its Bond Preventative Personal Security Platform) and with 24/7 support from its Personal Security Agents, who are in Bond Command Centers and can respond rapidly. It offers distinct services through its phone app (the Bond App) and fully automated Bond Command Centers. Geographically, the company operates in Israel, France, and United States. It derives maximum revenue from United States.

Share on Social Networks: